Goldman Sachs
CLOV icon

Goldman Sachs’s Clover Health Investments CLOV Stock Holding History

Goldman Sachs’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.13M Sell
1,170,742
-994,820
-46% -$3.38M ﹤0.01% 3699
2026
Q1 		$3.81M Buy
2,165,562
+384,323
+22% +$834K ﹤0.01% 3955
2025
Q4 		$4.19M Buy
1,781,239
+914,829
+106% +$2.5M ﹤0.01% 3906
2025
Q3 		$2.65M Sell
866,410
-1,494,774
-63% -$4.27M ﹤0.01% 4234
2025
Q2 		$6.59M Buy
2,361,184
+146,237
+7% +$481K ﹤0.01% 3154
2025
Q1 		$7.95M Sell
2,214,947
-75,281
-3% -$302K ﹤0.01% 2908
2024
Q4 		$7.21M Buy
2,290,228
+1,789,947
+358% +$6.4M ﹤0.01% 3086
2024
Q3 		$1.41M Sell
500,281
-216,048
-30% -$495K ﹤0.01% 4404
2024
Q2 		$881K Sell
716,329
-480,502
-40% -$431K ﹤0.01% 4492
2024
Q1 		$950K Buy
1,196,831
+642,873
+116% +$585K ﹤0.01% 4384
2023
Q4 		$527K Sell
553,958
-11,974
-2% -$11.8K ﹤0.01% 4716
2023
Q3 		$611K Sell
565,932
-179,938
-24% -$214K ﹤0.01% 4555
2023
Q2 		$669K Sell
745,870
-229,769
-24% -$204K ﹤0.01% 4583
2023
Q1 		$825K Buy
975,639
+151,931
+18% +$166K ﹤0.01% 4514
2022
Q4 		$766K Buy
823,708
+15,528
+2% +$20.7K ﹤0.01% 4596
2022
Q3 		$1.37M Buy
808,180
+73,643
+10% +$193K ﹤0.01% 4301
2022
Q2 		$1.57M Sell
734,537
-1,464,719
-67% -$3.89M ﹤0.01% 4256
2022
Q1 		$7.81M Buy
2,199,256
+797,158
+57% +$2.31M ﹤0.01% 2940
2021
Q4 		$5.21M Buy
1,402,098
+491,565
+54% +$3.01M ﹤0.01% 3369
2021
Q3 		$6.73M Buy
910,533
+737,828
+427% +$6.31M ﹤0.01% 3098
2021
Q2 		$2.3M Sell
172,705
-149,447
-46% -$1.47M ﹤0.01% 4080
2021
Q1 		$2.44M Buy
322,152
+304,302
+1,705% +$3.43M ﹤0.01% 3787
2020
Q4 		$299K Buy
+17,850
New +$199K ﹤0.01% 4887

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs's CLOV Position: Q2 2026 in Review

Goldman Sachs reduced its Clover Health Investments (CLOV) stake by 46% in Q2 2026, selling an estimated $3.38M and leaving 1,170,742 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

Goldman Sachs first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.95M in Q1 2025. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Goldman Sachs held 1,170,742 shares of Clover Health Investments worth $6.13M as of Q2 2026.
  • Goldman Sachs sold 994,820 Clover Health Investments shares in Q2 2026, an estimated $3.38M.
  • Clover Health Investments made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3699 holding.
  • Goldman Sachs first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Goldman Sachs's Clover Health Investments position peaked at $7.95M in Q1 2025.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.